|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Developing and intends to commercialize groundbreaking technologies for the treatment of spinal cord injuries (SCI). |
 |
| Management |
| Frank Reynolds - Chairman of the Board and CEO |
| |
|
|
|
|
|
|
|
| Keywords |
| Neurology , Neurological, spinal cord, SCI, |
|
|
|
| Description |
|
InVivo Therapeutics provides superior neurological products and services by delivering novel approaches to the treatment of disease that improve the quality of life and satisfy the needs of those who live with spinal cord injury. |
 |
 |
|
|
|
|
|
|